viridicatol

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Leukemia 10/16/2020 - "In this study, a mouse model of ovalbumin-induced food allergy and the rat basophil leukemia (RBL)-2H3 cell model were established to explore the anti-allergic properties of viridicatol. "
2.	Food Hypersensitivity (Food Allergy) 10/16/2020 - "In this study, a mouse model of ovalbumin-induced food allergy and the rat basophil leukemia (RBL)-2H3 cell model were established to explore the anti-allergic properties of viridicatol. "
3.	Neoplasms (Cancer) 10/17/2021 - "Viridicatol (13) displayed moderate anti-tumor activities against PANC-1, Hela, and A549 cells with IC50 values of around 20 μM. "
4.	Hypersensitivity (Allergy) 10/16/2020 - "On the basis of the mouse model, we found viridicatol to alleviate the allergy symptoms; decrease the levels of specific immunoglobulin E, mast cell protease-1, histamine, and tumor necrosis factor-α; and promote the production of interleukin-10 in the serum. "
5.	Anaphylaxis (Anaphylactic Shock) 10/16/2020 - "Viridicatol Isolated from Deep-Sea Penicillium Griseofulvum Alleviates Anaphylaxis and Repairs the Intestinal Barrier in Mice by Suppressing Mast Cell Activation."

1.	Anti-Allergic Agents (Antiallergic Agents)
2.	Ovalbumin
3.	Interleukin-10 (Interleukin 10)
4.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5.	Immunoglobulin E (IgE)
6.	Histamine (Histamine Dihydrochloride)